EW
Edwards Lifesciences
Earnings and EPS analysis
- Stocks
- Healthcare
- NYSE: EW
- Earnings
EPS in 2026 (TTM): $1.89
Last Report Period Date: Mar 31, 2026
As of June 2026, according to Edwards Lifesciences's latest financial report, the company's current EPS (TTM) is $1.89. Edwards Lifesciences's EPS for 2025 came in at $1.84, marking a decrease from $6.98 in 2024. Edwards Lifesciences's earnings per share for the quarterly report ending on Mar 31, 2026 was $0.66.
EW earnings history
The annual EPS in 2025 was $1.84, a decrease of 73.6% from $6.98 in 2024. The quarterly EPS for the period ending Mar 31, 2026, was $0.66, marking a 8.2% increase from the same quarter last year. EW's TTM EPS stands at $1.89 as of March 2026. Edwards Lifesciences's EPS for 2024 stood at $6.98, a 202.2% increase from 2023.
EW earnings chart
EW EPS growth history
Edwards Lifesciences has recorded an increase in EPS of 8.2% over the last 12 months (YoY, quarterly). For the last three years, EW recorded an average annual EPS growth rate of -9.2%. Edwards Lifesciences had an average annual EPS growth rate of 6.9% over the last 5 years. Across the last decade, EW had an average annual EPS growth of 9.1%.
EW Earnings Waterfall
EW Earnings vs Peers
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| BSX Boston Scientific Corp | 18.39 | 55.6% | 63.3% | N/A |
| MDT Medtronic plc | 21.14 | 3.3% | 9.8% | 6.9% |
| MMSI Merit Medical Systems Inc | 28.3 | 4.8% | 18.3% | N/A |
| LMAT Lemaitre Vascular Inc | 32.11 | 30.1% | 39.5% | 19.4% |
| EW Edwards Lifesciences Corp | 45.44 | -73.6% | -9.2% | 6.9% |
| ICUI Icu Medical Inc | 72.8 | 100.6% | N/A | -62.7% |
All data is based on quarterly TTM periods, unless otherwise specified.